|
Guide
to Clinical Preventive Service Summary of 2005
Recommendations of USPSTF for the AIM clinic |
(USPSTF grade) age |
Additional info |
||
|
(A)18 and over |
|
|||
|
(A)-Female >45, Male
>35 (B)-over 20 with CV risk
factors (B) test for tot.chol and
HDL |
(I) insuff. evidence for
checking Tg (C) for checking lipids in
over 20 -35 without risk factors |
|||
|
(B) pt with
HTN/hyperlipidemia; ** |
ADA-over 45y.o. overweight/obese, of highrisk ethnic groups, with family history of diabetes, or with hx gestational DM or babies>9lbs |
|||
|
(A) >21 or 3yrs after
activity, over 65/TAH see below |
(D) for over 65 with hx of
nl. Pap.or s/p TAH (I) for use of new
technology incld HPV |
|||
|
(B) over 40 q1-2 yrs |
(I) for clinical or self
breast exam |
|||
|
(A) over 50 |
yrly FOBT, colonoscopy,
etc… |
|||
|
(B) >65, for +RF >60 |
(C) for <60 and 60-64
not at incr. risk. -rescreening interval over 2 yrs |
|||
|
(B) screening |
|
|||
|
(B) screening and
counseling |
For all including pregnant women |
|||
|
(B) adults with dyslipid.,
other CV risk factors, diet related chronic dz |
(I) diet counseling in
unselected population |
|||
|
(B) screening of all, and
offer intens.counseling/behavioral mod |
|
|||
|
(A) for all incld pregnant
women |
Screening/counseling/ and
treatment |
|||
|
(A) for “at risk” (?10 yr
risk >6%) |
75mg daily effective |
|||
|
(B) 65-75 male smokers |
|
|||
|
PPD |
|
|||
|
<25 F or high risk- chlm. (A) GC (B) |
|
|||
|
Dental |
(B) counseling to visit
regularly |
From 1996 recommendation |
||
|
(A) at risk population |
(D) for asx not at risk pts |
|||
|
HIV |
(A) high risk, or in high
prevalence population |
Being cared for in CPMC
(??AIM) is considered to be high risk >1% prev. |
||
|
(A) pregnant women at first
visit |
(D) in general asx
population |
|||
|
(A) high risk and all
pregnant women |
(D) for asx persons not at
risk |
|||
|
(B) high risk pt, need to
balance risk vs. benefit |
(D) for primary prevention
for low or average risk |
*other
vaccinations see ADIP sheet *
|
D - Not Recommended §
Ovarian Ca §
§
testicular CA §
pancreatic CA §
use of vitamins
to prevent CA or CV dz, §
CAD screening
(in low risk) §
Hep C in asx.
population §
hormone therapy
in postmenopausal |
(I) insufficient evidence for or against §
glaucoma §
Hep C in hi risk
population §
CAD in high risk
population §
lung CA §
Oral CA §
|
Insufficient (continued) §
domestic
violence/abuse §
dementia in
elderly §
suicide risk in
gen. pop. §
Increase
physical activity §
Scoliosis in
adolescent §
Low back pain
prevention counseling |
Grade A-
USPSTF strongly recommends with good evidence that service improves impt.
health outcomes and concludes that benefits substantially outweighs harm.
Grade B –USPSTF
recommends to provide service to eligible pt, supported by at least fair
evidence that service improves impt. Health outcomes and conclude and benefit
outweighs harm.
Grade C-USPSTF
makes no recommendation for or against. The USPSTF found at least fair evidence
that service improves outcome, but conclude the balance of benefit and harm is
too close to justify a general recommendation.
Grade D-
USPSTF recommends against routinely providing service to asx patients. Found at
least fair evidence that the services is ineffective or that harm outweigh
benefits
Grade I-
USPSTF conclude evidence is insufficient to recommend for or against routinely
providing service. Evidence that the service is effective is lacking, or poor
quality, or conflicting, and the balance of benefit and harms cannot be
determined.